Moreover, based on the association of lncRNA ANRIL with a more malignant cancer phenotype in OSCC, we hypothesized that lncRNA ANRIL was involved in OSCC cell proliferation and sensitivity to cisplatin. This evidence concerns the gene CDKN2B-AS1 and cancer.